Thomas R. Kuhn, Executive Chairman and Director of Anterix Inc., filed a Form 4 on August 26, 2026, disclosing multiple transactions in the company's common stock between May 20, 2026, and August 24, 2026.
Key Highlights
- Option exercise: Kuhn exercised a stock option for 10,000 shares of common stock on August 24, 2026, at an exercise price of $33.62 per share.
- Shares sold on August 24, 2026: A total of 10,000 shares were sold in multiple transactions at weighted average prices ranging from $88.182 to $91.01 per share.
- RSU award: On May 20, 2026, Kuhn acquired 2,791 restricted stock units, each representing a contingent right to receive one share of common stock, vesting on the earlier of May 20, 2027, or the issuer's next annual stockholder meeting.
- Tax-related sale: On June 18, 2026, 1,654 shares were automatically sold at $79.52 per share in a non-discretionary transaction to cover tax withholding obligations upon RSU settlement.
- Remaining beneficial ownership: Following all reported transactions, Kuhn directly owned 17,731 shares of common stock and held 48,998 stock options (right to buy).
Anterix Executive Chairman's August 2026 Transactions in Detail
According to the filing, Thomas R. Kuhn serves as both Director and Executive Chairman of Anterix Inc. (NASDAQ:ATEX). On May 20, 2026, Kuhn received 2,791 restricted stock units as an acquisition. The filing states each RSU represents a contingent right to receive one share of the issuer's common stock, vesting in full on the earlier of May 20, 2027, or the issuer's next annual stockholder meeting, bringing his directly held shares to 19,385 at that point.
On June 18, 2026, 1,654 shares were disposed of at $79.52 per share. The filing describes this as an automatic, non-discretionary sale to cover tax withholding obligations upon the settlement of certain time-based RSU awards, reducing his direct holdings to 17,731 shares. On August 24, 2026, Kuhn exercised a stock option covering 10,000 shares at the exercise price of $33.62, with an expiration date of January 2, 2034. The filing notes that one-third of the option shares vest on January 2, 2025, with the remaining shares vesting in two equal annual installments thereafter.
Also on August 24, 2026, the filing reports four separate open-market sales totaling 10,000 shares. These were sold in tranches: 4,392 shares at a weighted average price of $88.182 (range $87.67 to $88.66), 4,418 shares at a weighted average price of $89.1187 (range $88.71 to $89.67), 790 shares at a weighted average price of $90.0009 (range $89.79 to $90.51), and 400 shares at $91.01. After all transactions, Kuhn's direct holdings stood at 17,731 shares of common stock, and his remaining directly held stock options totaled 48,998.
What Was Disclosed
The filing reported RSU grants, a tax-related share sale, a stock option exercise, and open-market sales of common stock by Anterix's Executive Chairman between May and August 2026, resulting in direct ownership of 17,731 shares and 48,998 remaining stock options.



Please wait processing your request...